Most recent update: Friday, August 18, 2017 - 11:04

Bariatric News - Cookies & privacy policy

- News

A non-toxic glue modelled after adhesive proteins produced by mussels and other creatures has been found to out-perform commercially available products, pointing toward potential surgical glues to replace sutures and staples. More than 230 million... (more)

18/08/17 - News

The American Society for Gastrointestinal Endoscopy (ASGE) and the Association for Bariatric Endoscopy (ABE), a Division of ASGE, has responded to the FDA’s letter alerting healthcare providers about potential risks of liquid-filled intragastric balloon devices. The letter... (more)
15/08/17 - News

After cardiac surgery, obese patients tend to require additional intensive care unit (ICU) services and longer recovery times when compared to non-obese patients. This results in more expensive, more labour-intensive care, according to a study published in The Annals of... (more)
14/08/17 - News

The FDA has issuing an update to alert health care providers of five reports of unanticipated deaths that occurred from 2016 to present in patients with liquid-filled intragastric balloon systems used to treat obesity. Four reports involve the Orbera Intragastric Balloon System... (more)

Laparoscopic training videos

16/08/17

Researchers at MIT and Massachusetts General Hospital have developed a new system that can efficiently search through hundreds of hours of...

11/08/17 - News

A person's fasting glucose levels may be useful in identifying the best type of diet for weight loss, according to researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University. The study focused on a weight-loss programme based on the... (more)
10/08/17 - News

blink Films are developing a television series looking at the increasing number of obese people in Britain who are physically or psychologically unable to leave their homes due to their weight. They want to provide expert help, which can include the cost of surgery.
09/08/17 - News

Investigators from Cedars-Sinai have developed a novel platform and protocol for testing the effects of endocrine disruptors on humans so show how they contribute to the obesity epidemic. The researchers tested three chemicals tested in the study to demonstrate how chronic... (more)

More news

09/08/17 - Research
Food preservatives and obesity
Investigators from Cedars-Sinai have developed a novel platform and protocol for testing the effects of endocrine disruptors on humans so show how they contribute to the obesity epidemic. The researchers tested three chemicals tested in the study to demonstrate how chronic exposure to these... (more)
07/08/17 - Research
Lifestyle-modification programmes
Most studies showed no significant reduction in body weight, and the meta-analysis confirmed that these lifestyle-modification programs were no more effective than as-usual treatments, according to a group of Lebanese investigators from the Department of Nutrition and Dietetics of Beirut Arab... (more)
04/08/17 - Research
Surgery cost-effective
Bariatric surgery is cost-effective at 10 years and may lead to significant cost-savings to health care system over the patient’s lifetime, according to researchers from the University Medical Center, Hamburg, Germany. In addition, the investigators found that any delay in a patient receiving... (more)
04/08/17 - Research
Gene therapy
A research team based at the University of Chicago has demonstrated how a novel approach with skin transplantation could enable a wide range of gene-based therapies to type-2 diabetes and obesity. Beginning in the 1970s, physicians learned how to harvest skin stem cells from a patient with... (more)
03/08/17 - Research
Fat shaming
Medical discrimination based on people's size and negative stereotypes of overweight people can take a toll on people's physical health and well-being, according to a review of recent research presented at the 125th Annual Convention of the American Psychological Association. "Disrespectful... (more)
01/08/17 - Research
Gelesis100 study
Gelesis has completed treatment in the pivotal GLOW (Gelesis Loss Of Weight) Study, a study designed to assess the long-term efficacy and safety of lead product candidate Gelesis100 over a six-month period across a broad patient population. The company has also enrolled its first European patient... (more)